Related Experiment Videos
Tumour vasculature--a potential therapeutic target
C T Baillie1, M C Winslet, N J Bradley
1University Department of Surgery, Royal Free Hospital and School of Medicine, London, UK.
British Journal of Cancer
|August 1, 1995
Summary
Tumor vasculature is crucial for cancer growth and spread. Targeting tumor blood vessels, through anti-angiogenesis or vascular antigens, shows promise for novel cancer therapies.
Area of Science:
- Oncology
- Vascular Biology
- Cancer Therapeutics
Background:
- Tumor vasculature is essential for solid tumor establishment, growth, and metastasis.
- The unique physiological properties of tumor vasculature impede conventional anti-cancer treatments.
- Understanding tumor vascularization is key to developing effective cancer therapies.
Purpose of the Study:
- To review therapeutic strategies targeting tumor vasculature.
- To evaluate the potential of anti-angiogenesis in cancer treatment.
- To explore the targeting of vascular proliferation antigens for cancer therapy.
Main Methods:
- Literature review of therapeutic approaches targeting tumor vasculature.
- Analysis of anti-angiogenesis strategies.
- Examination of vascular proliferation antigens as therapeutic targets.
Main Results:
- Tumor vasculature plays a critical role in cancer progression.
- Conventional therapies are limited by tumor vascular properties.
- Anti-angiogenesis and targeting vascular antigens are promising therapeutic avenues.
Conclusions:
- Targeting tumor vasculature offers a viable strategy for cancer treatment.
- Anti-angiogenesis represents a significant therapeutic approach.
- Targeting vascular proliferation antigens holds potential for future cancer therapies.